TRIM17
gene geneOn this page
Also known as terfRBCC
Summary
TRIM17 (tripartite motif containing 17, HGNC:13430) is a protein-coding gene on chromosome 1q42.13, encoding E3 ubiquitin-protein ligase TRIM17 (Q9Y577). E3 ubiquitin ligase that plays important roles in the regulation of neuronal apoptosis, selective autophagy or cell proliferation.
The protein encoded by this gene is a member of the tripartite motif (TRIM) family. The TRIM motif includes three zinc-binding domains, a RING, a B-box type 1 and a B-box type 2, and a coiled-coil region. The protein localizes to cytoplasmic bodies. The protein is expressed almost exclusively in the testis, but its function is unknown. Multiple alternatively spliced transcript variants have been found for this gene.
Source: NCBI Gene 51127 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 90 total
- MANE Select transcript:
NM_016102
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:13430 |
| Approved symbol | TRIM17 |
| Name | tripartite motif containing 17 |
| Location | 1q42.13 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | terf, RBCC |
| Ensembl gene | ENSG00000162931 |
| Ensembl biotype | protein_coding |
| OMIM | 606123 |
| Entrez | 51127 |
Gene structure
Transcript identifiers
Ensembl transcripts: 10 — 10 protein_coding
ENST00000295033, ENST00000355586, ENST00000366697, ENST00000366698, ENST00000456946, ENST00000457345, ENST00000479800, ENST00000520264, ENST00000882179, ENST00000882180
RefSeq mRNA: 3 — MANE Select: NM_016102
NM_001024940, NM_001134855, NM_016102
CCDS: CCDS1571, CCDS44327
Canonical transcript exons
ENST00000366698 — 7 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001069942 | 228409389 | 228409411 |
| ENSE00001069944 | 228413797 | 228413892 |
| ENSE00001069945 | 228410946 | 228411176 |
| ENSE00001413601 | 228416539 | 228416861 |
| ENSE00001416217 | 228414644 | 228415113 |
| ENSE00003789613 | 228409172 | 228409275 |
| ENSE00003841324 | 228407935 | 228408751 |
Expression profiles
Bgee: expression breadth ubiquitous, 133 present calls, max score 92.09.
FANTOM5 (CAGE): breadth broad, TPM avg 1.6471 / max 91.5525, expressed in 465 samples.
FANTOM5 promoters (9 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 17836 | 0.4278 | 232 |
| 17839 | 0.4218 | 214 |
| 17837 | 0.2545 | 115 |
| 17840 | 0.2487 | 119 |
| 17834 | 0.1177 | 58 |
| 17838 | 0.0758 | 29 |
| 17833 | 0.0433 | 28 |
| 17835 | 0.0385 | 14 |
| 17832 | 0.0190 | 5 |
Top tissues by expression
135 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right hemisphere of cerebellum | UBERON:0014890 | 92.09 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 91.92 | gold quality |
| cerebellar cortex | UBERON:0002129 | 91.86 | gold quality |
| cerebellum | UBERON:0002037 | 91.82 | gold quality |
| left testis | UBERON:0004533 | 88.96 | gold quality |
| right testis | UBERON:0004534 | 88.73 | gold quality |
| testis | UBERON:0000473 | 88.29 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 87.02 | gold quality |
| nucleus accumbens | UBERON:0001882 | 85.94 | gold quality |
| caudate nucleus | UBERON:0001873 | 83.83 | gold quality |
| right frontal lobe | UBERON:0002810 | 83.35 | gold quality |
| putamen | UBERON:0001874 | 82.58 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 81.29 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 81.02 | gold quality |
| frontal cortex | UBERON:0001870 | 80.19 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 79.71 | gold quality |
| cerebral cortex | UBERON:0000956 | 78.47 | gold quality |
| brain | UBERON:0000955 | 78.17 | gold quality |
| prefrontal cortex | UBERON:0000451 | 77.94 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 77.27 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 77.08 | gold quality |
| primary visual cortex | UBERON:0002436 | 76.99 | gold quality |
| right uterine tube | UBERON:0001302 | 76.72 | gold quality |
| Ammon’s horn | UBERON:0001954 | 76.46 | gold quality |
| temporal lobe | UBERON:0001871 | 73.06 | gold quality |
| spleen | UBERON:0002106 | 72.95 | gold quality |
| amygdala | UBERON:0001876 | 72.86 | gold quality |
| hypothalamus | UBERON:0001898 | 72.30 | gold quality |
| granulocyte | CL:0000094 | 71.20 | gold quality |
| right ovary | UBERON:0002118 | 70.92 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.22 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): NKX3-1
miRNA regulators (miRDB)
6 targeting TRIM17, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-33A-3P | 99.70 | 70.27 | 3362 |
| HSA-MIR-3059-5P | 99.70 | 69.93 | 2491 |
| HSA-MIR-1246 | 98.54 | 66.21 | 959 |
| HSA-MIR-4277 | 98.34 | 67.17 | 1323 |
| HSA-MIR-3650 | 97.88 | 64.89 | 693 |
| HSA-MIR-7848-3P | 95.69 | 65.00 | 363 |
Literature-anchored findings (GeneRIF, showing 9)
- terf interacts with TRIM44;TRIM44 inhibited ubiquitination of terf, and thus stabilized the protein. (PMID:19358823)
- the E3 ubiquitin ligase terf causes protein degradation of ZWINT and negatively regulates cell proliferation (PMID:22023800)
- NFATc3 interacted in a SUMO-dependent manner with Trim17, an E3 ubiquitin ligase necessary for neuronal apoptosis (PMID:25215946)
- TRIM17 promoted the removal of midbodies, remnants of the cell division machinery that are known autophagy targets. (PMID:27562068)
- overexpression of TRIM28 or knock-out of TRIM17 reduced BCLA1 protein levels and restored sensitivity of melanoma cells to BRAF-targeted therapy. Therefore, our data describe a molecular rheostat in which two proteins of the TRIM family antagonistically regulate BCL2A1 stability and modulate cell death. (PMID:30042493)
- deregulation of the TRIM17/TRIM41/ZSCAN21 pathway may be involved in the pathogenesis of Parkinson’s disease. (PMID:30485814)
- data suggest LSD1 largely plays a tumor suppressor role in luminal breast cancer and the oncogenic program associated with LSD1-inhibition may be suppressed via TRIM37-inhibition (PMID:31409898)
- MiR-1246 is responsible for lung cancer cells-derived exosomes-mediated promoting effects on lung cancer stemness via targeting TRIM17. (PMID:35894553)
- TRIM17-mediated ubiquitination and degradation of RBM38 promotes cisplatin resistance in non-small cell lung cancer. (PMID:37219768)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Trim17 | ENSMUSG00000036964 |
| rattus_norvegicus | Trim17 | ENSRNOG00000022983 |
Paralogs (80): MID2 (ENSG00000080561), TRIM9 (ENSG00000100505), MID1 (ENSG00000101871), MEFV (ENSG00000103313), TRIM35 (ENSG00000104228), TRIM14 (ENSG00000106785), TRIM37 (ENSG00000108395), TRIM2 (ENSG00000109654), TRIM3 (ENSG00000110171), TRIM38 (ENSG00000112343), TRIM62 (ENSG00000116525), TRIM67 (ENSG00000119283), TRIM32 (ENSG00000119401), BSPRY (ENSG00000119411), TRIM25 (ENSG00000121060), TRIM6 (ENSG00000121236), TRIM24 (ENSG00000122779), TRIM51 (ENSG00000124900), TRIM28 (ENSG00000130726), TRIM21 (ENSG00000132109), TRIM5 (ENSG00000132256), TRIM22 (ENSG00000132274), TRIM47 (ENSG00000132481), TRIM45 (ENSG00000134253), TRIM29 (ENSG00000137699), TRIM54 (ENSG00000138100), PML (ENSG00000140464), TRIM65 (ENSG00000141569), TRIM43B (ENSG00000144010), TRIM43 (ENSG00000144015), TRIM7 (ENSG00000146054), TRIM41 (ENSG00000146063), TRIM50 (ENSG00000146755), TRIM4 (ENSG00000146833), TRIM55 (ENSG00000147573), TRIM48 (ENSG00000150244), TRIM36 (ENSG00000152503), TRIM11 (ENSG00000154370), TRIM74 (ENSG00000155428), TRIM42 (ENSG00000155890)
Protein
Protein identifiers
E3 ubiquitin-protein ligase TRIM17 — Q9Y577 (reviewed: Q9Y577)
Alternative names: RING finger protein 16, RING-type E3 ubiquitin transferase TRIM17, Testis RING finger protein, Tripartite motif-containing protein 17
All UniProt accessions (5): E5RI62, E5RJW6, Q9Y577, J3KNZ3, J3KQG0
UniProt curated annotations — full annotation on UniProt →
Function. E3 ubiquitin ligase that plays important roles in the regulation of neuronal apoptosis, selective autophagy or cell proliferation. Stimulates the degradation of kinetochore ZW10 interacting protein ZWINT in a proteasome-dependent manner, leading to negative regulation of cell proliferation. Inhibits autophagic degradation of diverse known targets while contributing to autophagy of midbodies. Autophagy-inhibitory activity involves MCL1, which TRIM17 assembles into complexes with the key autophagy regulator BECN1. Controls neuronal apoptosis by mediating ubiquitination and degradation of MCL1 to initiate neuronal death. In addition, regulates NFAT transcription factors NFATC3 and NFATC4 activities by preventing their nuclear localization, thus inhibiting their transcriptional activities. Decreases TRIM41-mediated degradation of ZSCAN2 thereby stimulating alpha-synuclein/SNCA transcription in neuronal cells. Prevents the E3 ubiquitin-ligase activity of TRIM28 and its interaction with anti-apoptotic BCL2A1, blocking TRIM28 from ubiquitinating BCL2A1.
Subunit / interactions. Interacts (via coiled coil) with TRIM44 (via coiled coil). Interacts with TRIM28; this interaction prevents TRIM28 activity on BCL2A1. Interacts with TRIM41; this interaction prevents TRIM41 activity on ZSCAN2. Interacts with BECN1. Interacts with NFATC3 and NFATC4; these interactions prevent NFATC3 and NFATC4 nuclear localization.
Subcellular location. Cytoplasm. Lysosome.
Tissue specificity. Almost exclusively in the testis.
Post-translational modifications. Auto-ubiquitinated.
Pathway. Protein modification; protein ubiquitination.
Similarity. Belongs to the TRIM/RBCC family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9Y577-1 | 1 | yes |
| Q9Y577-2 | 2 |
RefSeq proteins (3): NP_001020111, NP_001128327, NP_057186* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000315 | Znf_B-box | Domain |
| IPR001841 | Znf_RING | Domain |
| IPR001870 | B30.2/SPRY | Domain |
| IPR003877 | SPRY_dom | Domain |
| IPR003879 | Butyrophylin_SPRY | Domain |
| IPR006574 | PRY | Domain |
| IPR013083 | Znf_RING/FYVE/PHD | Homologous_superfamily |
| IPR013320 | ConA-like_dom_sf | Homologous_superfamily |
| IPR017907 | Znf_RING_CS | Conserved_site |
| IPR027370 | Znf-RING_euk | Domain |
| IPR035687 | TRIM17_PRY/SPRY | Domain |
| IPR043136 | B30.2/SPRY_sf | Homologous_superfamily |
| IPR050143 | TRIM/RBCC | Family |
Pfam: PF00622, PF00643, PF13445
UniProt features (11 total): binding site 4, splice variant 2, zinc finger region 2, chain 1, domain 1, coiled-coil region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9Y577-F1 | 86.17 | 0.55 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (4): 99; 102; 121; 127
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-877300 | Interferon gamma signaling |
MSigDB gene sets: 45 (showing top):
REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP, GOBP_DEFENSE_RESPONSE_TO_OTHER_ORGANISM, GOBP_PROTEIN_AUTOUBIQUITINATION, SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN, GOBP_POST_TRANSLATIONAL_PROTEIN_MODIFICATION, MARSON_BOUND_BY_FOXP3_STIMULATED, GOMF_ACYLTRANSFERASE_ACTIVITY, GOMF_AMINOACYLTRANSFERASE_ACTIVITY, GOMF_UBIQUITIN_LIKE_PROTEIN_LIGASE_ACTIVITY, CHYLA_CBFA2T3_TARGETS_DN, GOBP_PROCESS_UTILIZING_AUTOPHAGIC_MECHANISM, DELACROIX_RAR_BOUND_ES, ALK_DN.V1_DN, NRL_DN.V1_DN
GO Biological Process (6): autophagy (GO:0006914), regulation of gene expression (GO:0010468), regulation of protein localization (GO:0032880), innate immune response (GO:0045087), protein autoubiquitination (GO:0051865), protein ubiquitination (GO:0016567)
GO Molecular Function (7): ubiquitin-protein transferase activity (GO:0004842), zinc ion binding (GO:0008270), protein-macromolecule adaptor activity (GO:0030674), ubiquitin protein ligase activity (GO:0061630), protein binding (GO:0005515), transferase activity (GO:0016740), metal ion binding (GO:0046872)
GO Cellular Component (2): cytoplasm (GO:0005737), lysosome (GO:0005764)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Interferon Signaling | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| catabolic process | 1 |
| transmembrane transport | 1 |
| process utilizing autophagic mechanism | 1 |
| gene expression | 1 |
| regulation of macromolecule biosynthetic process | 1 |
| intracellular protein localization | 1 |
| regulation of localization | 1 |
| immune response | 1 |
| defense response to symbiont | 1 |
| protein ubiquitination | 1 |
| protein modification by small protein conjugation | 1 |
| ubiquitin-like protein transferase activity | 1 |
| transition metal ion binding | 1 |
| protein binding | 1 |
| molecular adaptor activity | 1 |
| ubiquitin-protein transferase activity | 1 |
| ubiquitin-like protein ligase activity | 1 |
| binding | 1 |
| catalytic activity | 1 |
| cation binding | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
| lytic vacuole | 1 |
Protein interactions and networks
STRING
792 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TRIM17 | BBOX1 | O75936 | 977 |
| TRIM17 | RBCK1 | Q9BYM8 | 959 |
| TRIM17 | TRAT1 | Q6PIZ9 | 924 |
| TRIM17 | TRIM28 | Q13263 | 858 |
| TRIM17 | TRIM24 | O15164 | 804 |
| TRIM17 | TRIM9 | Q9C026 | 793 |
| TRIM17 | TRIM66 | O15016 | 786 |
| TRIM17 | TINF2 | Q9BSI4 | 780 |
| TRIM17 | TRIM67 | Q6ZTA4 | 755 |
| TRIM17 | PML | P29590 | 741 |
| TRIM17 | TRIM33 | Q9UPN9 | 731 |
| TRIM17 | TMLHE | Q9NVH6 | 715 |
| TRIM17 | PRY | O14603 | 694 |
| TRIM17 | KCNRG | Q8N5I3 | 573 |
| TRIM17 | TRIM32 | Q13049 | 571 |
IntAct
42 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TRIM39 | TRIM17 | psi-mi:“MI:0915”(physical association) | 0.860 |
| TRIM17 | TRIM39 | psi-mi:“MI:0915”(physical association) | 0.860 |
| HGS | TRIM17 | psi-mi:“MI:0915”(physical association) | 0.720 |
| TRIM41 | TRIM17 | psi-mi:“MI:0915”(physical association) | 0.670 |
| MEOX2 | TRIM17 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TRIM17 | HSP90AB1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| MLF1 | TRIM17 | psi-mi:“MI:0915”(physical association) | 0.400 |
| HSP90AB1 | TRIM17 | psi-mi:“MI:0915”(physical association) | 0.400 |
| TRIM17 | psi-mi:“MI:0915”(physical association) | 0.400 | |
| NUDC | TRIM17 | psi-mi:“MI:0915”(physical association) | 0.400 |
| NUDCD3 | TRIM17 | psi-mi:“MI:0915”(physical association) | 0.400 |
| TRIM17 | CACYBP | psi-mi:“MI:0915”(physical association) | 0.400 |
| TRIM17 | AARSD1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| TRIM17 | UBE2W | psi-mi:“MI:0915”(physical association) | 0.370 |
| UBE2D1 | TRIM17 | psi-mi:“MI:0915”(physical association) | 0.370 |
| TRIM17 | UBE2D2 | psi-mi:“MI:0915”(physical association) | 0.370 |
| TRIM17 | UBE2D3 | psi-mi:“MI:0915”(physical association) | 0.370 |
| UBE2H | TRIM17 | psi-mi:“MI:0915”(physical association) | 0.370 |
BioGRID (107): TRIM39 (Two-hybrid), TRIM39 (Two-hybrid), TRIM44 (Affinity Capture-MS), SNX2 (Affinity Capture-MS), TRIM17 (Reconstituted Complex), TRIM17 (Reconstituted Complex), TRIM17 (Two-hybrid), BCL2A1 (Affinity Capture-Western), TRIM17 (Affinity Capture-Western), TRIM28 (Affinity Capture-Western), TRIM28 (Co-localization), TRIM17 (Co-fractionation), TRIM17 (Affinity Capture-RNA), TRIM39 (Two-hybrid), TRIM17 (Two-hybrid)
ESM2 similar proteins: A0JN74, A6NCK2, A6NGJ6, A6NI03, B1H278, K7N6K2, O00478, O00481, P14373, P19474, Q13410, Q1ACD5, Q1ACD6, Q1ACD7, Q1ACD8, Q1XHU0, Q2YEM8, Q2YEM9, Q3ZEE5, Q587N6, Q5C8T6, Q5C8T8, Q5C8U1, Q5D7I9, Q5D7J0, Q5D7J1, Q5NCC9, Q5R996, Q62158, Q6MFZ5, Q7YR33, Q7YRV4, Q80V85, Q8BGE7, Q8NG06, Q923T7, Q96BQ3, Q96F44, Q99PP6, Q99PQ2
Diamond homologs: A0JN74, A6NCK2, A6NDI0, A6NGJ6, A6NI03, A6NK02, A6NLI5, B1H278, C9J1S8, K7N6K2, O00635, O15553, O19085, O77666, P0CI25, P0CI26, P14373, P15533, P18892, P19474, Q02084, Q0PF16, Q12899, Q13410, Q1ACD5, Q1ACD6, Q1ACD7, Q1ACD8, Q1XHU0, Q2T9Z0, Q2YEM8, Q2YEM9, Q2YEN0, Q2YEN2, Q3UWZ0, Q3ZEE5, Q495X7, Q587N6, Q587N7, Q58DK8
SIGNOR signaling
2 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| Ub:E2 | “up-regulates activity” | TRIM17 | ubiquitination |
| TRIM17 | “down-regulates quantity by destabilization” | MCL1 | polyubiquitination |
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 21 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Antigen processing: Ubiquitination & Proteasome degradation | 9 | 20.9× | 1e-08 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| protein K48-linked ubiquitination | 5 | 40.1× | 1e-05 |
| protein polyubiquitination | 7 | 38.5× | 6e-08 |
| ubiquitin-dependent protein catabolic process | 5 | 17.7× | 3e-04 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
90 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 66 |
| Likely benign | 10 |
| Benign | 5 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
833 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:228410943:CA:C | donor_loss | 1.0000 |
| 1:228410944:A:AC | donor_gain | 1.0000 |
| 1:228410945:C:CC | donor_gain | 1.0000 |
| 1:228410945:CCTG:C | donor_gain | 1.0000 |
| 1:228411173:TGCC:T | acceptor_gain | 1.0000 |
| 1:228411174:GCC:G | acceptor_gain | 1.0000 |
| 1:228411175:CCC:C | acceptor_gain | 1.0000 |
| 1:228411177:C:A | acceptor_loss | 1.0000 |
| 1:228411177:C:CC | acceptor_gain | 1.0000 |
| 1:228411178:T:C | acceptor_loss | 1.0000 |
| 1:228411180:C:CT | acceptor_gain | 1.0000 |
| 1:228411181:A:T | acceptor_gain | 1.0000 |
| 1:228413792:CCCA:C | donor_loss | 1.0000 |
| 1:228413793:CCAC:C | donor_loss | 1.0000 |
| 1:228413794:CACC:C | donor_loss | 1.0000 |
| 1:228413795:ACC:A | donor_loss | 1.0000 |
| 1:228413796:CC:C | donor_loss | 1.0000 |
| 1:228413889:TCAA:T | acceptor_gain | 1.0000 |
| 1:228413890:CAA:C | acceptor_gain | 1.0000 |
| 1:228413890:CAAC:C | acceptor_gain | 1.0000 |
| 1:228413891:AAC:A | acceptor_loss | 1.0000 |
| 1:228413892:AC:A | acceptor_loss | 1.0000 |
| 1:228413893:C:CA | acceptor_loss | 1.0000 |
| 1:228413893:C:CC | acceptor_gain | 1.0000 |
| 1:228413894:T:A | acceptor_loss | 1.0000 |
| 1:228414639:CCTAC:C | donor_loss | 1.0000 |
| 1:228414641:TAC:T | donor_loss | 1.0000 |
| 1:228414643:CCTTG:C | donor_loss | 1.0000 |
| 1:228408411:CGGGG:C | acceptor_gain | 0.9900 |
| 1:228408412:G:T | acceptor_gain | 0.9900 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000351108 (1:228412539 T>C), RS1000457459 (1:228411845 C>G,T), RS1000890667 (1:228416903 G>A), RS1001100528 (1:228417410 G>A), RS1001595743 (1:228414446 A>G), RS1001752263 (1:228417944 A>T), RS1001974677 (1:228409855 C>G), RS1001996470 (1:228411651 G>A), RS1002025669 (1:228409490 G>A,C,T), RS1002137909 (1:228415576 CTT>C), RS1002490379 (1:228415797 A>T), RS1002609501 (1:228407680 G>C), RS1002723970 (1:228416418 G>A,C,T), RS1003076069 (1:228410191 G>A), RS1003633626 (1:228418813 A>T)
Disease associations
OMIM: gene MIM:606123 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST006276_1 | Non-Richardson’s syndrome vs Richardson’s syndrome in progressive supranuclear palsy | 2.000000e-09 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
13 total (human), top 13 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| GSK-J4 | decreases expression | 1 |
| 2-palmitoylglycerol | increases expression | 1 |
| rofecoxib | affects expression | 1 |
| jinfukang | affects cotreatment, increases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Benzo(a)pyrene | affects methylation, decreases methylation | 1 |
| Cadmium | decreases expression | 1 |
| Cisplatin | affects cotreatment, increases expression | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Particulate Matter | increases abundance, increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): progressive supranuclear palsy